To OTC Journal Members: 
 
 

NFES Successfully Becomes NFEC

The reverse split has taken place, and the stock is in great shape. As I write today's update, NFEC, the old NFES post 3 for 1 reverse split, is now bid $5.25, offered $6.50 on 24,000 shares of volume. There were some very early prints at $20, which is just ridiculous. The Market Maker that filled that trade should be shot. If you were the buyer here's my adivce- always use a limit order or these guys will take you to the cleaners.

The price equivalent is $1.75bid, $2.16offer which is a new all time high for the stock. As the data populates throughout the system, and brokerage firms make the adjustments in accounts, I'm sure that spread will tighten. So far, so great.
 

Cel-Sci (AMEX: CVM): Breaking Out

There's a volume and price explosion on Cel-Sci (CVM)- my biotech idea that I brought to you at $.36 on June 13th. Today, the stock has traded over 30 million shares and is at the high end of its range for the day. Look at the chart.

The company just raised another $5 million on its way to getting into Phase III clinical trials for its cancer therapty Multikine. The market loves it. My price target on this one was $.75, so if you were in it for a trade you might want to think about locking in some profits as it approaches that level. That's more than a double in 60 days- 108% to be exact.

Longer term investors capable of thinking multiple years might look for far higher levels. This therapy could be worth billions down the road.
 
 
 
 
 

Xinhua (NASDAQ: XSEL): Looking Like a Technical Breakout

XSEL is having a really good day, and looking like it might want to break out. My weekend audio/video presentation on how the chart was setting up technically is looking spot on right now.

Here's a link to the presentation in case you missed it. Turn on your speakers.

http://www.otcjournal.com/Technical-Analysis-of-XSEL-August-24-2009/af/elearning/12/ 

As one of my readers pointed out yesterday, the stock just brought a very short term ascending wedge, which should put it on more traders' radar screens, and it's just as I predicted.

Fundamentally, there's still tons of upside here in my view. 

Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com